There are two main types of electronic muscle stimulation: transcutaneous electrical nerve stimulation (TENS) and electrical muscle stimulation (EMS). TENS can be used in treatment of chronic pain and acute pain. The current used in EMS is stronger than that of TENS.
The global muscle stimulation devices market is estimated to account for US$ 912.1 Mn in terms of value by the end of 2027.
Global Muscle Stimulation Devices Market: Drivers
Increasing prevalence of obesity is expected to propel growth of the global muscle stimulation devices market over the forecast period. For instance, according to MedAlertHelp.org, over 1.9 billion adults were reported as overweight worldwide.
Moreover, increasing healthcare expenditure is also expected to aid in growth of the market. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is projected to grow at an average rate of 5.5 % per year for 2018-27 and to reach nearly US$ 6.0 trillion by 2027.
Global Muscle Stimulation Devices Market: Restraints
Unclear regulatory guidance on commercial sales of muscle stimulation devices is expected to hinder growth of the market. The muscle stimulation devices market is marginally regulated by commercial guidelines, owing to lack of clarity about products. This has significantly hampered adoption of muscle stimulation devices for the treatment of several medical conditions.
Moreover, availability of substitute products such as creams, gels, and tablets is also expected to limit growth of the market.
The Pain management segment in the global muscle stimulation devices market was valued at US$ 314.6 Mn in 2019 and is expected to reach US$ 470.7 Mn by 2027 at a CAGR of 5.2% during the forecast period. Increasing incidence of head and spinal cord injuries is expected to boost growth of the segment over the forecast period.
The TENS segment held dominant position in the global muscle stimulation devices market in 2019, accounting for 71.5% share in terms of value, followed by NEMS. Increasing prevalence of obesity is expected to propel growth of the global muscle stimulation devices market over the forecast period.
Increasing adoption of portable TENS devices for the treatment of radiating pain in upper limbs and lower limbs is fueling growth of the market. Moreover, patients with sciatica, cervical spondylosis, and lumbar spondylosis also prefer non-invasive electrotherapy modalities such as TENS.
Interferential therapy (IFT) devices are used for the treatment of chronic low back pain and joint pain that arises from osteo-arthritis. Moreover, people suffering from osteoarthritis, rheumatoid arthritis, and frozen shoulder prefer portable electro therapy machines, i.e., combination of IFT, ultrasound, and muscle stimulators for the treatment of their painful joints.
Global Muscle Stimulation Devices Market: Competitive Landscape
Major players operating in the global muscle stimulation devices market include, DJO Global Inc., Zynex Inc., Neurometrix Inc., R.S. Medical Inc., and Omron Corporation.
Global Muscle Stimulation Devices Market: Key Developments
Major players in the market are focused on adopting collaboration strategies to expand their product portfolio. For instance, in November 2018, DJO Global, Inc. partnered with SirenMD, to become the exclusive sales representative for SirenMD’s sports team market.
Major players in the market are also focused on adopting various marketing strategies to expand their customer base. For instance, in December 2019, Zynex, Inc. attended the Piper Jaffray 31st Annual Healthcare Conference held in New York. (U.S.)
Scope of the report
“*” marked represents similar segmentation in other categories in the respective section.